Essex Financial Services’s CorMedix CRMD Stock Holding History

Essex Financial Services’s Portfolio CRMD Stock Details CRMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$92.9K	Sell	11,835 -84	-0.7%	-$664	﹤0.01%	826
2026 Q1	$80.9K	Buy	11,919 +1,208	+11%	+$8.93K	﹤0.01%	785
2025 Q4	$125K	Buy	10,711 +300	+3%	+$3.32K	0.01%	770
2025 Q3	$121K	Buy	+10,411	New	+$126K	0.01%	740
2025 Q2	–	Sell	-10,263	Closed	-$63.2K	–	692
2025 Q1	$63.2K	Buy	+10,263	New	+$106K	﹤0.01%	626
2019 Q4	–	Sell	-10,000	Closed	-$64K	–	273
2019 Q3	$64K	Buy	+10,000	New	+$84K	0.02%	247
2019 Q2	–	Sell	-10,000	Closed	-$95K	–	246
2019 Q1	$95K	Buy	+10,000	New	+$90.1K	0.03%	233

Other funds holding CRMD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Oberweis Asset Management Lisle, Illinois $4.84B AUM 160.95% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Essex Financial Services's CRMD Position: Q2 2026 in Review

Essex Financial Services reduced its CorMedix (CRMD) stake by 0.7% in Q2 2026, selling an estimated $664 and leaving 11,835 shares worth $92.9K. The position accounts for ﹤0.01% of the portfolio, ranked #826.

Essex Financial Services first reported a position in CRMD in Q1 2019 and has held it in 7 quarters since. The position peaked at $125K in Q4 2025. 193 funds tracked by Wall St. Rank hold CRMD as of Q2 2026.

Essex Financial Services held 11,835 shares of CorMedix worth $92.9K as of Q2 2026.
Essex Financial Services sold 84 CorMedix shares in Q2 2026, an estimated $664.
CorMedix made up ﹤0.01% of Essex Financial Services's portfolio in Q2 2026, its #826 holding.
Essex Financial Services first reported a position in CorMedix in Q1 2019 and has held it in 7 quarters since.
Essex Financial Services's CorMedix position peaked at $125K in Q4 2025.
193 funds tracked by Wall St. Rank held CorMedix as of Q2 2026.

Based on Essex Financial Services's 13F filing for Q2 2026, filed 10 Aug 2026.